Sweden Sees 56% Drop in Cervical Cancer Among Young Women Thanks to HPV Vaccination and Screening

Sweden has reported a remarkable 56% reduction in cervical cancer cases among women under 40 over the past decade. This significant decline is largely credited to the nationwide HPV vaccination program introduced for all fifth graders, including both girls and boys, along with regular cervical cancer screening initiatives. According to Ulrika Årehed Kågström, Secretary General of the Cancer Foundation, these statistics are "incredibly encouraging" but emphasize the need to intensify efforts to completely eradicate cervical cancer.

Regular HPV testing is crucial in preventing cervical cancer development; women who participate in screening reduce their risk by approximately 90%. Nonetheless, concerningly, about two-thirds of those diagnosed with cervical cancer have never taken part in screening. Tests can be conducted in healthcare settings with midwives or via home self-testing kits. Home testing has proven to be more effective and cost-efficient compared to clinic visits but is currently only widely available in about one-third of Sweden's regions.

Kågström has called for the Swedish government to take responsibility for ensuring wider access to home testing across all regions to boost screening participation further. The HPV vaccine program began in 2010 for girls and was extended to boys in 2020. Vaccinations remain free up to age 18, with recommendations to vaccinate unvaccinated individuals up to age 26.

Beyond cervical cancer, HPV is also linked to increased risks of penile, anal, and oropharyngeal cancers. The sustained reduction in cervical cancer cases represents a public health success but highlights the continuing necessity for nationwide screening efforts and vaccination coverage to aim toward the total elimination of cervical cancer in Sweden.